LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Caterpillar Mushroom to Treat OA?
Large Joints and Extremities

Caterpillar Mushroom to Treat OA?

April 27, 2015 1 min read Premium comments

Advertisement

Caterpillar Mushroom to Treat OA?
Dr Cornelia de Moor with the caterpillar fungus / Source: Arthritis Research: UK
Secondary

Scientists from the University of Nottingham are hoping that a drug from a parasitic mushroom that lives on caterpillars could be used to treat osteoarthritis (OA). The University of Nottingham researchers, led by Dr. Cornelia de Moor, say that this might occur within the next six years. Dr. de Moor and her team are investigating the possibility of using cordycepin—found in cordyceps mushrooms—as a painkiller.

“When we first started investigating this compound it was frankly a bit of a long-shot and there was much scepticism from the scientific community, ” Dr. de Moor said. “But we were stunned by the response from the pilot study, which showed that it was as effective as conventional painkillers in rats.

“This study is the first step in a potential drug development for a new class of drugs for osteoarthritis, although there are a number of hurdles we have to go through—necessarily so—before it gets nearer patients. To the best of our knowledge, cordycepin has never been tested as a lead compound for osteoarthritis pain.”

According to the news release, “Cordycepin blocks the inflammatory process that cause pain in osteoarthritis, but does so in a completely different way and at a different stage in the process to existing painkillers such as corticosteroids and non-steroidal-anti-inflammatory drugs (NSAIDs) such as ibuprofen.”

“Dr. de Moor will investigate whether cordycepin acts on the knee joint or on the nerves that relay painful messages from the knee to the spinal cord, and the mechanism by which cordycepin inhibits pain.”

She adds, “The lack of quality control means that cordyceps preparations for sale in Europe rarely contain much cordycepin, and may contain other harmful compounds.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy